Before asking the FDA to record a formal meeting, sponsors should consider the potential benefits and risks of the move, attorney Jim Czaban said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
